We examined microsatellite instability and loss of heterozygosity (LOH) in primary lung tumors from 93 cancer patients, using 16 microsatellite markers. The cases studied included 87 non-small-cell lung cancers (NSCLC) and six small-cell lung cancers (SCLC). All the patients except two were current
Synchronous multiple primary gastrointestinal cancer exhibits frequent microsatellite instability
✍ Scribed by Hiroshi Ohtani; Masakazu Yashiro; Naoyoshi Onoda; Nobuaki Nishioka; Yasuyuki Kato; Shinji Yamamoto; Shoji Fukushima; Kosei Hirakawa-Ys Chung
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- French
- Weight
- 125 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Colorectal (CRC) and gastric cancers (GC), the most common gastrointestinal malignancies, have been known to develop occasionally in a same patient. Previous studies have focused on the etiology of patients with multiple primary gastric and colorectal cancer (MPGCC); however, the carcinogenic process of MPGCC remains unclear. In this study, we have examined the genetic alterations in MPGCC in order to clarify the carcinogenic pathway. Twenty patients with sporadic MPGCC were examined for microsatellite instability (MSI) and frameshift mutations of target genes such as TGFRII, BAX and IGFIIR. In 10 (50%) of 20 patients with MPGCC, MSI was present at least at 1 lesion of GC or CRC. Four (50%) of 8 cases with synchronous MPGCC displayed MSI in both GC and CRC, while only 1 (8%) of 12 cases of metachronous MPGCC exhibited MSI in both organs. Carcinogenic process of MPGCC was fairly associated with the MSI pathway, particularly in cases of synchronous MPGCC. MSI was found in 5 (25%) of 20 GCs and in 10 (50%) of 20 CRCs. MSI was involved more closely in CRC than in GC among MPGCC. Although most frameshift mutations at target genes were found in the MSI-positive MPGCC, infrequent mutations were observed in the genes. Frameshift mutation was found in only 1 of 5 cases of MSI-positive GC at TGFRII. Only 2 of 10 cases of CRC with MSI showed mutation at TGFRII, and 1 case also showed mutation at BAX and IGFIIR. Our findings suggest that TGFRII, BAX and IGFIIR are not the main target genes for carcinogenesis in MSI-positive MPGCC.
📜 SIMILAR VOLUMES